Latest On NextCure, Inc (NXTC):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-05 03:59 EST | News | NextCure GAAP EPS of -$0.58 beats by $0.04 | N/A |  |
| 2023-03-02 20:07 EST | News | NextCure GAAP EPS of -$2.69 misses by $0.04 | N/A | |
| 2022-11-15 23:06 EST | News | NextCure, South Korea's LegoChem Biosciences to develop antibody drug conjugates | N/A | |
| 2022-11-04 06:27 EST | News | NextCure GAAP EPS of -$0.68 misses by $0.02 | N/A | |
| 2022-08-05 06:10 EST | News | NextCure GAAP EPS of -$0.65 beats by $0.09 | N/A | |
| 2022-06-16 05:41 EST | News | NextCure (NXTC) Investor Presentation - Slideshow | N/A | |
| 2022-05-06 06:02 EST | News | NextCure GAAP EPS of -$0.74 misses by $0.07 | N/A | |
| 2022-03-04 09:13 EST | News | NextCure GAAP EPS of -$2.51 | N/A | |
| 2022-02-26 07:06 EST | News | NextCure (NXTC) Presents At Global Healthcare Virtual Conference - Slideshow | N/A | |
| 2021-11-05 11:05 EST | News | NextCure EPS beats by $0.02 | N/A | |
| 2021-09-29 20:40 EST | News | NextCure: Large Upside With Downside Protected By Cash Pile | N/A | |
| 2021-09-22 02:30 EST | News | NextCure (NXTC) Presents At H. C. Wainwright 23rd Annual Global Investment Conference - Slideshow | N/A | |
| 2021-09-11 01:54 EST | News | NextCure (NXTC) Presents At The 19th Annual Morgan Stanley Virtual Global Healthcare Conference - Slideshow | N/A | |
| 2021-08-06 08:09 EST | News | NextCure EPS misses by $0.04 | N/A | |
| 2021-05-07 13:04 EST | News | NextCure EPS misses by $0.01 | N/A | |
| 2021-04-15 23:56 EST | News | NextCure (NXTC) Presents At 20th Annual Needham Healthcare Conference - Slideshow | N/A | |
| 2021-03-16 21:37 EST | Analyst Rating | The Analyst Target Price has decreased from $23.33 to $19.38. | Neutral | |
| 2021-03-08 08:21 EST | Analyst Rating | The Analyst Target Price has increased from $22.67 to $23.33. | Buy | |
| 2021-03-06 00:05 EST | News | NextCure raised to buy at Truist after R&D event | N/A | |
| 2021-03-05 20:23 EST | Financials | Company financials have been released. | Neutral | |
| 2021-03-05 12:07 EST | Analyst Rating | The Analyst Target Price has decreased from $23.33 to $22.67. | Neutral | |
| 2021-03-05 12:07 EST | Earnings Estimate | An EPS average of -$2.89 is estimated for the 2022 year. | Sell | |
| 2021-03-05 12:07 EST | Earnings Estimate | An EPS average of -$0.65 is estimated for the quarter ending on June 30, 2021. | Sell | |
| 2021-03-05 02:41 EST | News | NextCure EPS beats by $0.01, revenue in-line | N/A | |
| 2021-01-18 08:12 EST | Analyst Rating | The Analyst Target Price has decreased from $23.67 to $23.33. | Neutral | |
| 2021-01-14 23:30 EST | News | NextCure appoints new chief medical officer | N/A | |
| 2020-12-17 21:49 EST | News | NextCure provides update on NC318 clinical program | N/A | |
| 2020-11-26 21:03 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-09 20:40 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-09 12:53 EST | Earnings Estimate | An EPS average of -$0.59 is estimated for the quarter ending on March 31, 2021. | N/A | |
| 2020-11-08 00:24 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 16:41 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 13:50 EST | News | NextCure EPS misses by $0.02 | N/A | |
| 2020-09-26 13:36 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 05:42 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-25 16:11 EST | News | What's Next For NextCure | N/A | |
| 2020-08-14 09:40 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-10 05:27 EST | Analyst Rating | The Analyst Target Price has decreased from $25.89 to $23.67. | Neutral | |
| 2020-08-09 13:23 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-08 00:19 EST | News | Mixed shelf roundup - healthcare | N/A | |
| 2020-08-07 17:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 23:30 EST | News | NextCure EPS misses by $0.03 | N/A | |
| 2020-08-06 21:29 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 13:25 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-31 01:52 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 17:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 05:21 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 13:17 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 17:57 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-20 17:26 EST | Analyst Rating | The Analyst Target Price has decreased from $65.88 to $25.89. | Neutral | |
About NextCure, Inc (NXTC):
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The company is also developing NC410, which is in Phase I for novel immunomedicine designed to block immune suppression mediated by an immune modulator called Leukocyte-Associated Immunoglobulin-like Receptor 1; and NC762, an immunomedicine targeting a molecule called human B7 homolog 4 protein, or B7-H4. Its discovery and research programs include an antibody in preclinical evaluation of other potential novel immunomodulatory molecules. NextCure, Inc. has a license agreement with Yale University. The company was incorporated in 2015 and is headquartered in Beltsville, Maryland.
General
- Name NextCure, Inc
- Symbol NXTC
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 90
- Fiscal Year EndDecember
- IPO Date2019-05-09
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Web URLhttp://www.nextcure.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 14.64
- Price/Book (Most Recent Quarter) 1.12
- Enterprise Value Revenue 2.17
- Enterprise Value EBITDA 0.18
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$2.51
- Next Year EPS Estimate -$2.79
- Next Quarter EPS Estimate -$0.62
- Profit Margin -164%
- Operating Margin -184%
- Return on Assets -8%
- Return on Equity -12%
- Revenue 22.38 million
- Earnings Per Share -$1.92
- Revenue Per Share $0.81
- Gross Profit -24176000
- Quarterly Earnings Growth -100%
View More
Highlights
- Market Capitalization 336.17 million
- EBITDA -26598000
- Analyst Target Price $19.38
- Book Value Per Share $10.65
View More
Share Statistics
- Shares Outstanding 27.6 million
- Shares Float 19.54 million
- % Held by Insiders 1433%
- % Held by Institutions 74.9%
- Shares Short 1.58 million
- Shares Short Prior Month 1.94 million
- Short Ratio 7.27
- Short % of Float 6%
- Short % of Shares Outstanding 6%
View More
Technicals
- 52 Week High $40.94
- 52 Week Low $7.91
- 50 Day Moving Average 12.32
- 200 Day Moving Average 11.03
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
NextCure, Inc (NXTC) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
NextCure, Inc (NXTC) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-03-04 | $N/A | -$0.54 | -$0.60 | 9.67% |
| 2020-09-30 | 2020-11-05 | $N/A | -$0.59 | -$0.57 | -4.19% |
| 2020-06-30 | 2020-08-06 | $N/A | -$0.53 | -$0.50 | -5.31% |
| 2020-03-31 | 2020-05-07 | $N/A | $0.33 | -$0.44 | 174.51% |
| 2019-12-31 | 2020-03-12 | $2.01 million | -$0.34 | -$0.45 | 25.16% |
| 2019-09-30 | 2019-11-12 | $1.58 million | -$0.37 | -$0.35 | -5.71% |
| 2019-06-30 | 2019-08-12 | $1.4 million | -$0.61 | -$0.47 | -31.18% |
| 2019-03-31 | 2019-05-09 | $1.36 million | -$4.46 | -$0.53 | -741.51% |
NextCure, Inc (NXTC) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Research Development | 12.11 million | N/A | N/A | N/A | 33.73 million |
| Income Before Tax | -15.46 million | N/A | N/A | N/A | -10.93 million |
| Selling General Administrative | 4.13 million | N/A | N/A | N/A | 2.62 million |
| Gross Profit | N/A | N/A | N/A | N/A | 24.34 million |
| Ebit | -16.24 million | N/A | N/A | N/A | -12.01 million |
| Operating Income | -16.24 million | N/A | N/A | N/A | -12.01 million |
| Income Tax Expense | N/A | N/A | N/A | N/A | N/A |
| Total Revenue | N/A | N/A | N/A | N/A | 2.01 million |
| Cost of Revenue | N/A | N/A | N/A | N/A | -22.34 million |
| Total Other Income Expense Net | 776000 | 1.03 million | N/A | N/A | 1.08 million |
| Net Income From Continuing Operations | -15.46 million | -16.37 million | N/A | N/A | -10.93 million |
| Net Income Applicable to Common Shares | -15.46 million | -16.37 million | -14.51 million | 9.73 million | -10.93 million |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | N/A | N/A | N/A | -126.35 million | -174.21 million |
| Change to Liabilities | -2.25 million | 172000 | -21.98 million | -2.22 million | -497000 |
| Total Cash Flow from Investing Activities | 13.1 million | 8.55 million | 5.37 million | -127.16 million | -174.7 million |
| Net Borrowings | -417000 | -417000 | -277000 | N/A | N/A |
| Total Cash Flow from Financial Activities | N/A | N/A | N/A | 161.31 million | -112000 |
| Change to Operating Activities | -314000 | -1.05 million | -110000 | 1.83 million | -328000 |
| Change in Cash | N/A | N/A | N/A | 24.16 million | -182.75 million |
| Total Cash from Operating Activities | -15.67 million | -12.41 million | -10.59 million | -9.99 million | -7.95 million |
| Depreciation | N/A | N/A | N/A | 755000 | 788000 |
| Other Cash Flow from Investing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Inventory | N/A | N/A | N/A | N/A | N/A |
| Change to Account Receivables | N/A | N/A | N/A | N/A | N/A |
| Other Cash Flow from Financing Activities | N/A | N/A | N/A | 134000 | -134000 |
| Change to Net Income | 2.37 million | 2.19 million | 1.01 million | 567000 | 524000 |
| Capital Expenditures | N/A | N/A | N/A | 814000 | 490000 |
Balance Sheet:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Total Liabailities | 12.92 million | N/A | N/A | N/A | 34.68 million |
| Total Stockholder Equity | 293.72 million | 307.34 million | N/A | N/A | 321.48 million |
| Other Current Liabilities | 130000 | 134000 | N/A | N/A | 6.64 million |
| Total Assets | 306.64 million | N/A | N/A | N/A | 356.17 million |
| Common Stock | 28000 | 28000 | 28000 | 28000 | 27000 |
| Other Current Assets | 1.71 million | 1.71 million | N/A | N/A | 1.71 million |
| Retained Earnings | -117.64 million | -102.18 million | -85.81 million | -71.3 million | -81.03 million |
| Other Liabilities | 792000 | 776000 | 571000 | 507000 | 16.31 million |
| Other Assets | 2.86 million | 3.28 million | 3.59 million | 4.02 million | 4.08 million |
| Cash | 32.77 million | N/A | N/A | N/A | 34.09 million |
| Total Current Liabilities | 10.33 million | 5.74 million | N/A | N/A | 15.04 million |
| Other Stockholder Equity | 779000 | 1.3 million | 1.94 million | -543000 | -38000 |
| Property, Plant & Equipment | 15.81 million | 15.82 million | 14.83 million | 12.78 million | 12.09 million |
| Total Current Assets | 287.98 million | 296.98 million | N/A | N/A | 340 million |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | 293.72 million | 307.34 million | 321.92 million | 331.76 million | 321.48 million |
| Short Term Investments | 250.68 million | 268.67 million | N/A | N/A | 300.51 million |
| Long Term Debt | 1.81 million | N/A | N/A | N/A | 3.33 million |
| Inventory | N/A | N/A | N/A | N/A | N/A |
| Accounts Payable | 3.9 million | 186000 | N/A | N/A | 1.86 million |
NextCure, Inc (NXTC) Chart:
NextCure, Inc (NXTC) News:
Below you will find a list of latest news for NextCure, Inc (NXTC) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
NextCure, Inc (NXTC) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2024-05-17 | 2.5 | 0.05 | CALL | 0 | 81 | 245.32 | FALSE | 0 | 0 |
| 2024-05-17 | 5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 7.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 2.5 | 1.2 | PUT | 0 | 4 | 613.23 | TRUE | 0 | 0 |
| 2024-05-17 | 5 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-05-17 | 7.5 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-06-21 | 2.5 | 0.15 | CALL | 0 | 55 | 151.55 | FALSE | 0 | 0 |
| 2024-06-21 | 5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 7.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 2.5 | 0 | PUT | 0 | 0 | 315.37 | TRUE | 0 | 0 |
| 2024-06-21 | 5 | 0 | PUT | 0 | 0 | 320.49 | TRUE | 0 | 0 |
| 2024-06-21 | 7.5 | 0 | PUT | 0 | 0 | 753.76 | TRUE | 0 | 0 |
| 2024-09-20 | 2.5 | 0.05 | CALL | 0 | 105 | 131.35 | FALSE | 0 | 0 |
| 2024-09-20 | 5 | 0.4 | CALL | 0 | 20 | 252.51 | FALSE | 0 | 0 |
| 2024-09-20 | 7.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 2.5 | 1.15 | PUT | 0 | 50 | 90.35 | TRUE | 0 | 0 |
| 2024-09-20 | 5 | 0 | PUT | 0 | 0 | 613.03 | TRUE | 0 | 0 |
| 2024-09-20 | 7.5 | 0 | PUT | 0 | 0 | 316.78 | TRUE | 0 | 0 |
| 2024-12-20 | 2.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 5 | 0 | CALL | 0 | 0 | 254.89 | FALSE | 0 | 0 |
| 2024-12-20 | 7.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 2.5 | 0 | PUT | 0 | 0 | 167.38 | TRUE | 0 | 0 |
| 2024-12-20 | 5 | 0 | PUT | 0 | 0 | 225.49 | TRUE | 0 | 0 |
| 2024-12-20 | 7.5 | 0 | PUT | 0 | 0 | 423.34 | TRUE | 0 | 0 |
Latest NXTC Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:58 PM EST | 200 | $4.645 |
| Jun 13, 2022 7:58 PM EST | 300 | $4.645 |
| Jun 13, 2022 7:59 PM EST | 9 | $4.645 |
| Jun 13, 2022 7:59 PM EST | 100 | $4.63 |
| Jun 13, 2022 7:59 PM EST | 13 | $4.64 |
NextCure, Inc (NXTC) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329220000885/0001123292-20-000885-index.htm |
| 2019-02-25 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1661059/000000000019003113/0000000000-19-003113-index.htm |
| 2019-03-13 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1661059/000000000019004619/0000000000-19-004619-index.htm |
| 2019-11-06 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1661059/000000000019015264/0000000000-19-015264-index.htm |
| 2019-05-22 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1661059/000007800319000029/0000078003-19-000029-index.htm |
| 2020-10-26 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1661059/000089542120000516/0000895421-20-000516-index.htm |
| 2019-01-30 | DRS | Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1661059/000091205719000030/0000912057-19-000030-index.htm |
| 2019-03-05 | DRS/A | Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1661059/000091205719000071/0000912057-19-000071-index.htm |
| 2019-04-01 | DRS/A | Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1661059/000091205719000136/0000912057-19-000136-index.htm |
| 2019-10-30 | DRS | Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1661059/000091205719000425/0000912057-19-000425-index.htm |
| 2019-11-18 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1661059/000092963819001005/0000929638-19-001005-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1661059/000092963820000330/0000929638-20-000330-index.htm |
| 2020-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1661059/000093041320000375/0000930413-20-000375-index.htm |
| 2019-05-21 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1661059/000094787119000387/0000947871-19-000387-index.htm |
| 2019-11-19 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1661059/000094787119000830/0000947871-19-000830-index.htm |
| 2019-04-12 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1661059/000104746919002203/0001047469-19-002203-index.htm |
| 2019-04-29 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1661059/000104746919002652/0001047469-19-002652-index.htm |
| 2019-05-03 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1661059/000104746919002857/0001047469-19-002857-index.htm |
| 2019-05-08 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1661059/000104746919002935/0001047469-19-002935-index.htm |
| 2019-05-09 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1661059/000104746919002988/0001047469-19-002988-index.htm |
| 2019-05-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1661059/000104746919003060/0001047469-19-003060-index.htm |
| 2019-11-12 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1661059/000104746919006237/0001047469-19-006237-index.htm |
| 2019-11-14 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1661059/000104746919006303/0001047469-19-006303-index.htm |
| 2019-11-18 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1661059/000104746919006335/0001047469-19-006335-index.htm |
| 2020-04-27 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1661059/000104746920002583/0001047469-20-002583-index.htm |
| 2019-04-17 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1661059/000110465919021960/0001104659-19-021960-index.htm |
| 2019-05-06 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1661059/000110465919027155/0001104659-19-027155-index.htm |
| 2019-05-08 | 8-A12B | Registration of securities [Section 12(b)] | https://www.sec.gov/Archives/edgar/data/1661059/000110465919027670/0001104659-19-027670-index.htm |
| 2019-05-13 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1661059/000110465919029015/0001104659-19-029015-index.htm |
| 2019-05-13 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1661059/000110465919029017/0001104659-19-029017-index.htm |
| 2019-08-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1661059/000110465919045001/0001104659-19-045001-index.htm |
| 2019-10-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1661059/000110465919052393/0001104659-19-052393-index.htm |
| 2019-11-12 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1661059/000110465919062669/0001104659-19-062669-index.htm |
| 2019-11-12 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1661059/000110465919062672/0001104659-19-062672-index.htm |
| 2019-11-14 | S-1MEF | Registration adding securities to prior Form S-1 registration [Rule 462(b)] | https://www.sec.gov/Archives/edgar/data/1661059/000110465919064433/0001104659-19-064433-index.htm |
| 2019-11-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000110465919065582/0001104659-19-065582-index.htm |
| 2019-11-22 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1661059/000110465919066346/0001104659-19-066346-index.htm |
| 2019-12-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1661059/000110465919068982/0001104659-19-068982-index.htm |
| 2020-01-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1661059/000110465920003214/0001104659-20-003214-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1661059/000110465920021710/0001104659-20-021710-index.htm |
| 2020-03-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1661059/000110465920039889/0001104659-20-039889-index.htm |
| 2020-04-27 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1661059/000110465920051303/0001104659-20-051303-index.htm |
| 2020-06-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1661059/000110465920072403/0001104659-20-072403-index.htm |
| 2020-07-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1661059/000110465920083106/0001104659-20-083106-index.htm |
| 2020-07-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1661059/000110465920084546/0001104659-20-084546-index.htm |
| 2020-07-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1661059/000110465920089093/0001104659-20-089093-index.htm |
| 2020-08-06 | S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers | https://www.sec.gov/Archives/edgar/data/1661059/000110465920091521/0001104659-20-091521-index.htm |
| 2020-09-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1661059/000110465920104856/0001104659-20-104856-index.htm |
| 2019-05-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329219000721/0001123292-19-000721-index.htm |
| 2019-05-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329219000722/0001123292-19-000722-index.htm |
| 2019-05-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329219000723/0001123292-19-000723-index.htm |
| 2019-05-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329219000724/0001123292-19-000724-index.htm |
| 2019-05-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329219000725/0001123292-19-000725-index.htm |
| 2019-05-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329219000726/0001123292-19-000726-index.htm |
| 2019-05-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329219000727/0001123292-19-000727-index.htm |
| 2019-05-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329219000728/0001123292-19-000728-index.htm |
| 2019-05-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329219000729/0001123292-19-000729-index.htm |
| 2019-05-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329219000730/0001123292-19-000730-index.htm |
| 2019-05-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329219000731/0001123292-19-000731-index.htm |
| 2019-05-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329219000732/0001123292-19-000732-index.htm |
| 2019-05-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329219000733/0001123292-19-000733-index.htm |
| 2019-05-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329219000734/0001123292-19-000734-index.htm |
| 2019-05-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329219000735/0001123292-19-000735-index.htm |
| 2019-05-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329219000736/0001123292-19-000736-index.htm |
| 2019-05-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329219000737/0001123292-19-000737-index.htm |
| 2019-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329219000748/0001123292-19-000748-index.htm |
| 2019-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329219000749/0001123292-19-000749-index.htm |
| 2019-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329219000750/0001123292-19-000750-index.htm |
| 2019-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329219000751/0001123292-19-000751-index.htm |
| 2019-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329219000752/0001123292-19-000752-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329219000886/0001123292-19-000886-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329219000887/0001123292-19-000887-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329219000888/0001123292-19-000888-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329219000889/0001123292-19-000889-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329219000890/0001123292-19-000890-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329219000891/0001123292-19-000891-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329219000892/0001123292-19-000892-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329219000893/0001123292-19-000893-index.htm |
| 2020-02-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329220000301/0001123292-20-000301-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329220000457/0001123292-20-000457-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329220000458/0001123292-20-000458-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329220000459/0001123292-20-000459-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329220000460/0001123292-20-000460-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329220000461/0001123292-20-000461-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329220000462/0001123292-20-000462-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329220000463/0001123292-20-000463-index.htm |
| 2020-04-01 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329220000634/0001123292-20-000634-index.htm |
| 2020-04-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1661059/000112329220000663/0001123292-20-000663-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329220000878/0001123292-20-000878-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329220000879/0001123292-20-000879-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329220000880/0001123292-20-000880-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329220000881/0001123292-20-000881-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329220000882/0001123292-20-000882-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329220000883/0001123292-20-000883-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329220000884/0001123292-20-000884-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329220000885/0001123292-20-000885-index.htm |
| 2020-07-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329220000983/0001123292-20-000983-index.htm |
| 2020-09-14 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329220001085/0001123292-20-001085-index.htm |
| 2020-09-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000112329220001087/0001123292-20-001087-index.htm |
| 2016-01-11 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1661059/000114036116047469/0001140361-16-047469-index.htm |
| 2019-05-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000114420419024597/0001144204-19-024597-index.htm |
| 2019-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000114420419026681/0001144204-19-026681-index.htm |
| 2019-05-17 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1661059/000114420419026919/0001144204-19-026919-index.htm |
| 2019-05-17 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1661059/000114420419026954/0001144204-19-026954-index.htm |
| 2020-02-21 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1661059/000117266120000940/0001172661-20-000940-index.htm |
| 2020-02-06 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1661059/000119312520026457/0001193125-20-026457-index.htm |
| 2020-02-13 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1661059/000121390020003681/0001213900-20-003681-index.htm |
| 2019-05-08 | CERT | Certification | https://www.sec.gov/Archives/edgar/data/1661059/000135445719000262/0001354457-19-000262-index.htm |
| 2019-01-30 | DRSLTR | Correspondence Related to Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1661059/000141057819000043/0001410578-19-000043-index.htm |
| 2019-03-05 | DRSLTR | Correspondence Related to Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1661059/000141057819000117/0001410578-19-000117-index.htm |
| 2019-04-01 | DRSLTR | Correspondence Related to Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1661059/000141057819000168/0001410578-19-000168-index.htm |
| 2019-06-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1661059/000155837019005589/0001558370-19-005589-index.htm |
| 2019-08-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1661059/000155837019007974/0001558370-19-007974-index.htm |
| 2019-11-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1661059/000155837019010701/0001558370-19-010701-index.htm |
| 2020-03-12 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1661059/000155837020002566/0001558370-20-002566-index.htm |
| 2020-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1661059/000155837020005800/0001558370-20-005800-index.htm |
| 2020-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1661059/000155837020009660/0001558370-20-009660-index.htm |
| 2020-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1661059/000155837020012866/0001558370-20-012866-index.htm |
| 2018-11-19 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1661059/000156761918006604/0001567619-18-006604-index.htm |
| 2019-05-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000172202419000006/0001722024-19-000006-index.htm |
| 2019-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661059/000172202419000008/0001722024-19-000008-index.htm |
| 2019-05-08 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1661059/999999999519001046/9999999995-19-001046-index.htm |
| 2019-11-14 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1661059/999999999519002590/9999999995-19-002590-index.htm |
| 2019-04-29 | SEC STAFF | SEC Staff Letter: REDACTED EXHIBIT | https://www.sec.gov/Archives/edgar/data/1661059/999999999719003597/9999999997-19-003597-index.htm |
| 2019-05-07 | SEC STAFF | SEC Staff Letter: REDACTED EXHIBIT | https://www.sec.gov/Archives/edgar/data/1661059/999999999719003992/9999999997-19-003992-index.htm |
| 2020-02-10 | SEC STAFF | SEC Staff Letter: REDACTED EXHIBIT | https://www.sec.gov/Archives/edgar/data/1661059/999999999720000621/9999999997-20-000621-index.htm |
| 2020-02-19 | SEC STAFF | SEC Staff Letter: REDACTED EXHIBIT | https://www.sec.gov/Archives/edgar/data/1661059/999999999720000806/9999999997-20-000806-index.htm |
NextCure, Inc (NXTC) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of NextCure, Inc (NXTC). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 1433%Institutional Ownership: 7490%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2019-05-13 | Stella Xu | Director | Buy | 125,000.00 | 15.00 | 1,875,000.00 | 1,103,570.00 | https://www.sec.gov/Archives/edgar/data/1661059/000112329219000750/0001123292-19-000750-index.htm |
| 2019-05-13 | TIMOTHY M SHANNON | Director | Buy | 50,000.00 | 15.00 | 750,000.00 | 2,254,442.00 | https://www.sec.gov/Archives/edgar/data/1661059/000112329219000752/0001123292-19-000752-index.htm |
| 2019-05-13 | X L.P. CANAAN | 10% Share Holder | Buy | 50,000.00 | 15.00 | 750,000.00 | 2,254,442.00 | https://www.sec.gov/Archives/edgar/data/1661059/000112329219000749/0001123292-19-000749-index.htm |
| 2019-05-13 | Sofinnova Venture Partners IX, L.P. | 10% Share Holder | Buy | 400,000.00 | 15.00 | 6,000,000.00 | 2,521,856.00 | https://www.sec.gov/Archives/edgar/data/1661059/000114420419026681/0001144204-19-026681-index.htm |
| 2019-11-15 | Sofinnova Venture Partners IX, L.P. | 10% Share Holder | Buy | 150,000.00 | 36.75 | 5,512,500.00 | 2,671,856.00 | https://www.sec.gov/Archives/edgar/data/1661059/000110465919065582/0001104659-19-065582-index.htm |
| 2019-05-13 | Chau Quang Khuong | Director | Buy | 350,000.00 | 15.00 | 5,250,000.00 | 2,711,013.00 | https://www.sec.gov/Archives/edgar/data/1661059/000112329219000751/0001123292-19-000751-index.htm |
| 2019-05-13 | ORBIMED ADVISORS LLC | Director | Buy | 350,000.00 | 15.00 | 5,250,000.00 | 2,711,013.00 | https://www.sec.gov/Archives/edgar/data/1661059/000112329219000748/0001123292-19-000748-index.htm |
| 2019-11-27 | Linda Liu | SVP, Research | Buy | 34,489.00 | 0.48 | 16,554.72 | 34,489.00 | https://www.sec.gov/Archives/edgar/data/1661059/000112329220000301/0001123292-20-000301-index.htm |
| 2020-07-14 | Kevin N. Heller | Chief Medical Officer | Buy | 27,229.00 | 1.77 | 48,195.33 | 49,011.00 | https://www.sec.gov/Archives/edgar/data/1661059/000112329220000983/0001123292-20-000983-index.htm |
| 2019-11-27 | Linda Liu | SVP, Research | Buy | 20,745.00 | 1.21 | 25,101.45 | 55,234.00 | https://www.sec.gov/Archives/edgar/data/1661059/000112329220000301/0001123292-20-000301-index.htm |